1. Home
  2. BELFB vs IDYA Comparison

BELFB vs IDYA Comparison

Compare BELFB & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bel Fuse Inc. Class B

BELFB

Bel Fuse Inc. Class B

HOLD

Current Price

$242.65

Market Cap

3.4B

Sector

N/A

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$39.98

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BELFB
IDYA
Founded
1949
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.6B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
BELFB
IDYA
Price
$242.65
$39.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
16
Target Price
$174.25
$52.86
AVG Volume (30 Days)
150.6K
701.7K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
0.11%
N/A
EPS Growth
N/A
61.90
EPS
N/A
N/A
Revenue
$491,611,000.00
$218,710,000.00
Revenue This Year
$9.74
N/A
Revenue Next Year
$6.34
$201.05
P/E Ratio
$42.80
N/A
Revenue Growth
N/A
3024.43
52 Week Low
$129.94
$23.23
52 Week High
$335.29
$42.68

Technical Indicators

Market Signals
Indicator
BELFB
IDYA
Relative Strength Index (RSI) 37.27 58.13
Support Level $219.03 $33.57
Resistance Level $248.61 $39.93
Average True Range (ATR) 10.61 1.35
MACD -3.11 0.09
Stochastic Oscillator 3.26 59.26

Price Performance

Historical Comparison
BELFB
IDYA

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: